BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 24732458)

  • 1. Reactivation of mucosal and cutaneous leishmaniasis in a renal transplanted patient.
    Tuon FF; Bombonatto GM; Battaglin ER; Sakumoto MH; Amato VS; de Camargo RA; Nicodemo AC
    Am J Trop Med Hyg; 2014 Jul; 91(1):81-3. PubMed ID: 24732458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Refractory mucocutaneous leishmaniasis resolved with combination treatment based on intravenous pentamidine, oral azole, aerosolized liposomal amphotericin B, and intralesional meglumine antimoniate.
    Basile G; Cristofaro G; Locatello LG; Vellere I; Piccica M; Bresci S; Maggiore G; Gallo O; Novelli A; Di Muccio T; Gramiccia M; Gradoni L; Gaiera G; Bartoloni A; Zammarchi L
    Int J Infect Dis; 2020 Aug; 97():204-207. PubMed ID: 32505874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Good response to pentamidine isethionate in a case of Mucosal Leishmaniasis caused by Leishmania (Viannia) braziliensis that was difficult to treat: Case Report.
    Ferreira Terceiro BR; Torraca TSS; Braga FPB; Martins ACDC; Brahim LR; Saheki MN; Miranda LFC; Schubach AO; Valete-Rosalino CM
    Rev Soc Bras Med Trop; 2019 Jan; 52():e20180236. PubMed ID: 30652793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous leishmaniasis with secondary mucosal disease in a traveller due to Leishmania (Viannia) braziliensis.
    Crone CG; Helleberg M
    J Travel Med; 2020 Feb; 27(1):. PubMed ID: 31776570
    [No Abstract]   [Full Text] [Related]  

  • 5. Case Report: Mucosal Leishmaniasis in New York City.
    Murray HW; Eiras DP; Kirkman LA; Chai RL; Caplivski D
    Am J Trop Med Hyg; 2020 Jun; 102(6):1319-1322. PubMed ID: 32228792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical complexity of Leishmania (Viannia) braziliensis infections amongst travelers.
    Eichner S; Thoma-Uszynski S; Herrgott I; Sebald H; Debus A; Tsianakas A; Ehrchen J; Harms G; Simon M; Sunderkötter C; Bogdan C
    Eur J Dermatol; 2013 Apr; 23(2):218-23. PubMed ID: 23557633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucocutaneous leishmaniasis: report of a case with massive involvement of nasal, pharyngeal and laryngeal mucosa.
    Di Lella F; Vincenti V; Zennaro D; Afeltra A; Baldi A; Giordano D; Pasanisi E; Bacciu A; Bacciu S; Di Lella G
    Int J Oral Maxillofac Surg; 2006 Sep; 35(9):870-2. PubMed ID: 16574379
    [No Abstract]   [Full Text] [Related]  

  • 8. Mucosal leishmaniasis: description of case management approaches and analysis of risk factors for treatment failure in a cohort of 140 patients in Brazil.
    Amato VS; Tuon FF; Imamura R; Abegão de Camargo R; Duarte MI; Neto VA
    J Eur Acad Dermatol Venereol; 2009 Sep; 23(9):1026-34. PubMed ID: 19453817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case Report: Unusual Presentation of Pharyngeal Mucosal Leishmaniasis due to
    Figueiredo LP; Almeida LDC; Magalhães A; Arruda S; Lessa MM; Carvalho EM
    Am J Trop Med Hyg; 2020 Oct; 103(4):1493-1495. PubMed ID: 32748768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposomal amphotericin B treatment of Old World cutaneous and mucosal leishmaniasis: A literature review.
    Mosimann V; Neumayr A; Paris DH; Blum J
    Acta Trop; 2018 Jun; 182():246-250. PubMed ID: 29550282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary Prophylaxis with Liposomal Amphotericin B in a Patient with Mucosal Leishmaniasis Undergoing Immunobiological Therapy for Active Ankylosing Spondylitis.
    Nicodemo AC; de Andrade HF; Muñoz Torres P; Amato VS
    Am J Trop Med Hyg; 2019 Aug; 101(2):402-403. PubMed ID: 31219006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of liposomal amphotericin B in disseminated cutaneous leishmaniasis caused by Leishmania braziliensis in a pediatric patient with Down syndrome.
    Sandoval-Juárez A; Rojas-Palomino N; Roca LK; Pilares-Barco G; Cuadros-Castro J; Araujo-Castillo R
    Rev Peru Med Exp Salud Publica; 2023; 40(1):94-98. PubMed ID: 37377243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure of Liposomal-amphotericin B Treatment for New World Cutaneous Leishmaniasis due to Leishmania braziliensis.
    Kosaka A; Sakamoto N; Hikone M; Imai K; Ota M; Washino T; Maeda T; Iwabuchi S
    Intern Med; 2020; 59(9):1227-1230. PubMed ID: 32378656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and Safety of Liposomal Amphotericin B for the Treatment of Mucosal Leishmaniasis from the New World: A Retrospective Study.
    Cunha MA; Leão AC; de Cassia Soler R; Lindoso JA
    Am J Trop Med Hyg; 2015 Dec; 93(6):1214-8. PubMed ID: 26483120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucosal leishmaniasis in Brazilian patients: two case reports with similar clinical presentation and different approaches.
    Cruz AF; Resende RG; Albuquerque DR; de Lacerda JC; Leite CF; Ferreira Aguiar MC
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Dec; 122(6):e199-e203. PubMed ID: 27234853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. American tegumentary leishmaniasis: diagnostic and treatment challenges in a clinical case.
    Oyama J; Ferreira FBP; Conter CC; Lera-Nonose DSSL; Ramos-Milaré ÁCFH; Venazzi EAS; Silveira TGV; Lonardoni MVC
    Rev Inst Med Trop Sao Paulo; 2018; 60():e3. PubMed ID: 29451600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous occurrence of cutaneous and mucocutaneous leishmaniasis caused by different genotypes of Leishmania (Viannia) braziliensis.
    Hoyos CL; Quipildor M; Bracamonte E; Lauthier JJ; Cajal P; Uncos A; Korenaga M; Hashiguchi Y; Barroso PA; Marco JD
    J Dermatol; 2019 Sep; 46(9):e320-e322. PubMed ID: 30938461
    [No Abstract]   [Full Text] [Related]  

  • 18. Mucosal leishmaniasis . Current scenario and prospects for treatment.
    Amato VS; Tuon FF; Bacha HA; Neto VA; Nicodemo AC
    Acta Trop; 2008 Jan; 105(1):1-9. PubMed ID: 17884002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of Disseminated Leishmaniasis With Liposomal Amphotericin B.
    Machado PR; Rosa ME; Guimarães LH; Prates FV; Queiroz A; Schriefer A; Carvalho EM
    Clin Infect Dis; 2015 Sep; 61(6):945-9. PubMed ID: 26048961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study on liposomal amphotericin B and other therapies in the treatment of mucosal leishmaniasis: A 15-year retrospective cohort study.
    Santos CR; Tuon FF; Cieslinski J; de Souza RM; Imamura R; Amato VS
    PLoS One; 2019; 14(6):e0218786. PubMed ID: 31242231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.